This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ho, A. T.
Right arrow Articles by Zacksenhaus, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ho, A. T.
Right arrow Articles by Zacksenhaus, E.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, August 2007, p. 5673-5685, Vol. 27, No. 16
0270-7306/07/$08.00+0     doi:10.1128/MCB.00188-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

XIAP Activity Dictates Apaf-1 Dependency for Caspase 9 Activation{triangledown} ,{dagger}

Andrew T. Ho,1,2 Qin H. Li,1 Hitoshi Okada,5,6 Tak W. Mak,2,5,6 and Eldad Zacksenhaus1,2,3,4*

Division of Cell and Molecular Biology, Toronto General Research Institute-University Health Network, 67 College Street, Toronto, Ontario, Canada M5G 2M1,1 Departments of Medical Biophysics,2 Laboratory Medicine and Pathobiology,3 Medicine,4 Immunology, University of Toronto,5 The Campbell Family Institute for Breast Cancer Research, Princess Margaret Hospital, 620 University Avenue, Toronto, Ontario, Canada M5G 2C16

Received 31 January 2007/ Returned for modification 30 March 2007/ Accepted 4 June 2007

The current model for the intrinsic apoptotic pathway holds that mitochondrial activation of caspases in response to cytotoxic drugs requires both Apaf-1-induced dimerization of procaspase 9 and Smac/Diablo-mediated sequestration of inhibitors of apoptosis proteins (IAPs). Here, we showed that either pathway can independently promote caspase 9 activation in response to apoptotic stimuli. In drug-treated Apaf-1/ primary myoblasts, but not fibroblasts, Smac/Diablo accumulates in the cytosol and sequesters X-linked IAP (XIAP), which is expressed at lower levels in myoblasts than in fibroblasts. Consequently, caspase 9 activation proceeds in Apaf-1/ myoblasts; concomitant ablation of Apaf-1 and Smac is required to prevent caspase 9 activation and the onset of apoptosis. Conversely, in stimulated Apaf-1/ fibroblasts, the ratio of XIAP to Smac/Diablo is high compared to that for myoblasts and procaspase 9 is not activated. Suppressing XIAP with exogenous Smac/Diablo or a pharmacological inhibitor can still induce caspase 9 in drug-treated Apaf-1-null fibroblasts. Thus, caspase 9 activation in response to intrinsic apoptotic stimuli can be uncoupled from Apaf-1 in vivo by XIAP antagonists.


* Corresponding author. Mailing address: Division of Cell & Molecular Biology, Toronto General Research Institute-University Health Network, 67 College Street, Rm. 407, Toronto, Ontario, Canada M5G 2M1. Phone: (416) 340-4800, ext. 5106. Fax: (416) 340-3453. E-mail: eldad.zacksenhaus{at}utoronto.ca

{triangledown} Published ahead of print on 11 June 2007.

{dagger} Supplemental material for this article may be found at http://mcb.asm.org/.


Molecular and Cellular Biology, August 2007, p. 5673-5685, Vol. 27, No. 16
0270-7306/07/$08.00+0     doi:10.1128/MCB.00188-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Murray, T. V. A., McMahon, J. M., Howley, B. A., Stanley, A., Ritter, T., Mohr, A., Zwacka, R., Fearnhead, H. O. (2008). A non-apoptotic role for caspase-9 in muscle differentiation. J. Cell Sci. 121: 3786-3793 [Abstract] [Full Text]  
  • Vogler, M., Walczak, H., Stadel, D., Haas, T. L., Genze, F., Jovanovic, M., Gschwend, J. E., Simmet, T., Debatin, K.-M., Fulda, S. (2008). Targeting XIAP Bypasses Bcl-2-Mediated Resistance to TRAIL and Cooperates with TRAIL to Suppress Pancreatic Cancer Growth In vitro and In vivo. Cancer Res. 68: 7956-7965 [Abstract] [Full Text]